Celltrion
068270.KS
#799
Rank
โ‚น3.108 T
Marketcap
โ‚น13,554
Share price
-0.50%
Change (1 day)
24.26%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): โ‚น227.53

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น241.16. In 2025 the company made an earnings per share (EPS) of โ‚น295.05 an increase over its 2024 EPS that were of โ‚น111.90.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น227.53-22.88%
2025โ‚น295.05163.66%
2024โ‚น111.90-53.73%
2023โ‚น241.86-2.08%
2022โ‚น247.00-11.72%
2021โ‚น279.792.03%
2020โ‚น274.2182.8%
2019โ‚น150.0018.31%
2018โ‚น126.79-36.33%
2017โ‚น199.14161.25%
2016โ‚น76.232.86%
2015โ‚น74.1117.84%
2014โ‚น62.895.87%
2013โ‚น59.40-70.85%
2012โ‚น203.78134.09%
2011โ‚น87.0543.59%
2010โ‚น60.6374.49%
2009โ‚น34.74317.8%
2008โ‚น8.32-71.7%
2007โ‚น29.38